Medlit Blitz by Mark2Cure and Cochrane Crowd – May 9th to May 12th

Citizen science has enormous potential, and Mark2Cure and the Cochrane Crowd’s volunteers are helping explore its application towards biomedical discovery. Cochrane Crowd and Mark2Cure will be hosting a webinar on May 8th and there will be two 24hr screening challenges. There will be prizes for the top three contributors who take part in both the Cochrane Crowd and Mark2Cure screening challenges. Here are the details:

Mark2Cure/Cochrane Crowd Webinar:
Date/Time: May 08, 2017, 9:00am – 10:00am PDT

Tentative agenda:

Intro (5 minutes)
Mark2Cure presentation (15 mins)
Cochrane Crowd presentation (15 mins)
MedLit Blitz (5 minutes)
Audience Q&A (15-20 mins)
Interested in participating in the webinar? You’ll need to register first! Hurry, space is limited (due to limitations/licensing restrictions) of the webinar software. Register here

Medlit Blitz (2 x 24 hr screening challenges):

Cochrane Challenge: Help Cochrane Crowd identify studies that provide the best possible evidence of the effectiveness of a health treatment. Once identified by the Crowd the studies go into a central register where health researchers and practitioners can access them. The more studies identified by the Crowd, the more high-quality evidence is available to help health practitioners treat their clients.

Challenge Start: May 9th, 2017 10am GMT + 1 (UK time zone) / 2am (PDT)
Challenge Finish: May 10th, 2017 10am GMT + 1 (UK time zone) / 2am (PDT)

Mark2Curathon: Join the search for clues on a rare disease by identifying genes, diseases, drugs, and the relationships between these based on literature surrounding the NGLY1.

Challenge Start: May 11th, 2017 7pm GMT + 1 (UK time zone) / 11am (PDT)
Challenge Finish: May 12th, 2017 7pm GMT + 1 (UK time zone) / 11am (PDT)

Get ready to use your reading skills to make a difference in biomedical science and health !

More info:
http://sulab.org/2017/04/webinar-mark2curathon-and-more/
http://community.cochrane.org/news/join-medlit-blitz

Be the first to comment

Leave a Reply

Your email address will not be published.


*